144 related articles for article (PubMed ID: 23002928)
21. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.
Ciocca M; Cantone MC; Veronese I; Cattani F; Pedroli G; Molinelli S; Vitolo V; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e305-11. PubMed ID: 21708432
[TBL] [Abstract][Full Text] [Related]
22. Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability.
López-Tarjuelo J; Bouché-Babiloni A; Santos-Serra A; Morillo-Macías V; Calvo FA; Kubyshin Y; Ferrer-Albiach C
Radiother Oncol; 2014 Nov; 113(2):283-9. PubMed ID: 25465728
[TBL] [Abstract][Full Text] [Related]
23. [Significance of automation in the blood transfusion service--from the viewpoint of pre-transfusion tests at a hospital].
Tamura M; Matsuda H; Suzuki A
Rinsho Byori; 1983 Aug; 31(8):819-34. PubMed ID: 6655915
[No Abstract] [Full Text] [Related]
24. Anticipating risk for human subjects participating in clinical research: application of Failure Mode and Effects Analysis.
Cody RJ
Cancer Invest; 2006 Mar; 24(2):209-14. PubMed ID: 16537191
[TBL] [Abstract][Full Text] [Related]
25. Quality risk analysis in a cGMP environment: multiple models for comprehensive failure mode identification during the computer system lifecycle.
Gervais B; D'Arcy DM
Drug Dev Ind Pharm; 2014 Jan; 40(1):46-60. PubMed ID: 23216278
[TBL] [Abstract][Full Text] [Related]
26. Using Failure Mode and Effects Analysis to Evaluate Risk in the Clinical Adoption of Automated Contouring and Treatment Planning Tools.
Nealon KA; Balter PA; Douglas RJ; Fullen DK; Nitsch PL; Olanrewaju AM; Soliman M; Court LE
Pract Radiat Oncol; 2022; 12(4):e344-e353. PubMed ID: 35305941
[TBL] [Abstract][Full Text] [Related]
27. Challenges experienced during pharmacy automation and robotics implementation in JCI accredited hospital in the Arabian Gulf area: FMEA analysis-qualitative approach.
ElLithy MH; Alsamani O; Salah H; Opinion FB; Abdelghani LS
Saudi Pharm J; 2023 Sep; 31(9):101725. PubMed ID: 37638225
[TBL] [Abstract][Full Text] [Related]
28. A streamlined failure mode and effects analysis.
Ford EC; Smith K; Terezakis S; Croog V; Gollamudi S; Gage I; Keck J; DeWeese T; Sibley G
Med Phys; 2014 Jun; 41(6):061709. PubMed ID: 24877804
[TBL] [Abstract][Full Text] [Related]
29. Risk analysis of the preanalytical process based on quality indicators data.
Flegar-Meštrić Z; Perkov S; Radeljak A; Kardum Paro MM; Prkačin I; Devčić-Jeras A
Clin Chem Lab Med; 2017 Mar; 55(3):368-377. PubMed ID: 27580180
[TBL] [Abstract][Full Text] [Related]
30. Minimizing treatment planning errors in proton therapy using failure mode and effects analysis.
Zheng Y; Johnson R; Larson G
Med Phys; 2016 Jun; 43(6):2904-2910. PubMed ID: 27277039
[TBL] [Abstract][Full Text] [Related]
31. The blood bank software of your dreams.
Butch SH
CAP Today; 2001 Oct; 15(10):30-4, 36-8, 40 passim. PubMed ID: 11695172
[No Abstract] [Full Text] [Related]
32. [Computer management to avoid errors in transfusion].
Takahashi K
Rinsho Byori; 2003 Jan; 51(1):63-70. PubMed ID: 12652693
[TBL] [Abstract][Full Text] [Related]
33. The role of automated gel column testing technology in enhancing transfusion safety.
Noumsi G
MLO Med Lab Obs; 2014 Jul; 46(7):34, 36. PubMed ID: 25158402
[No Abstract] [Full Text] [Related]
34. Maximizing the benefits of type and screen by continued surveillance of transfusion practice.
Davis SP; Barrasso C; Ness PM
Am J Med Technol; 1983 Aug; 49(8):579-82. PubMed ID: 6670674
[TBL] [Abstract][Full Text] [Related]
35. Cost containment and simplification in the blood bank.
Polesky HF
Clin Lab Med; 1985 Dec; 5(4):793-9. PubMed ID: 4085192
[TBL] [Abstract][Full Text] [Related]
36. The implementation and use of automated group and screen procedures in a hospital transfusion laboratory.
Growe GH; Galenza J; Mah H; Whitehead R; Godolphin W
Transfus Med Rev; 1996 Apr; 10(2):144-51. PubMed ID: 8721971
[No Abstract] [Full Text] [Related]
37. New techniques for compatibility testing.
Plapp FV
Arch Pathol Lab Med; 1989 Mar; 113(3):262-9. PubMed ID: 2493236
[TBL] [Abstract][Full Text] [Related]
38. Events at blood collection area due to nonconforming blood bags and plateletpheresis kits: need for timely corrective and preventive actions.
Verma A; Sachan D; Elhence P; Pandey H; Dubey A
Transfusion; 2012 Jul; 52(7 Pt 2):1622-7. PubMed ID: 22780944
[TBL] [Abstract][Full Text] [Related]
39. [Quality and safety about hemapheresis practicing: from a self-evaluation of medical practices to a systematic risk management process].
Lefèvre PA; Audat F; Giraud C; Roussel P
Transfus Clin Biol; 2010 Apr; 17(2):69-80. PubMed ID: 20674436
[TBL] [Abstract][Full Text] [Related]
40. Containing costs in the blood bank by reducing unnecessary crossmatching.
Friedman BA
Pathologist; 1984 Jul; 38(7):405-10. PubMed ID: 10267505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
